FDA Expands Rozlytrek Indication to Include Some Solid Tumors in Children at Least 1 Month Old
The Food and Drug Administration (FDA) approved an expanded indication for Rozlytrek (entrectinib) to include children older than one...
Oct 23, 2023
Study shows that genomic tumor profiling of pediatric tumors can enhance clinical care
Results of a study of molecular tumor profiling in young patients revealed a high rate of genetic alterations with potential for...
Jun 24, 2022
Pushing T cells down "memory lane" may improve cancer therapy
Scientists at St. Jude Children's Research Hospital identified proteins that help decide T cell fate and used the finding to improve...
Jun 23, 2022
New Treatment Developed by Children's Hospital of Philadelphia Shows Success in High-Risk Solid
Now, in a breakthrough study, researchers at Children's Hospital of Philadelphia (CHOP) have shown that an enhanced treatment developed...
Aug 26, 2020
Engineered immune cells target broad range of pediatric solid tumors in mice
In mouse studies, a Stanford-led team has developed an engineered immune cell that eliminates several types of childhood tumors. The...
Jan 17, 2019